Public reporting burden for this coiiection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information. including suggestions for reducing this burden to Washington Headquarters Services, Directorate for Information Operations and Reports, 1215 Jefferson Davis Highway, Suite 1104, Arlington, VA 22202-4302, and to the Oflice of Management and Budget, Paperwork Reduction Project (0704-0188), Washington, DC 20503.
AGENCY USE ONLY (Leave blank)
AUTHOR(S)Sue C. Heffelfinger, M.D., Ph.D.
PERFORMING ORGANIZATION NAME(S) AND ADDRESS(ES) 8. PERFORMING ORGANIZATION REPORT NUMBER
University of CincinnatiCincinnati, Ohio 45267-0553
SPONSORING/MONITORING AGENCY NAME(S) AND ADDRESS(ES) 10. SPONSORING/MONITORING
ABSTRACT (Maximum 200Tumor growth is absolutely dependent upon angiogenesis. Prior to the development of breast cancer, the breast tissue in many women undergoes progressive changes which include proliferative breast disease and carcinoma in situ. We examined these pathologic changes for the level of vascularity and the presence of angiogenic growth factors in the hopes of identifying targets for chemoprophylaxis. To date, we have shown that angiogenesis begins in the earliest stages of progression. In addition, even normal breast tissue contains numerous angiogenic factors; however, these are insufficient to induce angiogenesis. Using an in vitro organ culture system of normal breast tissue, we found that exogenous angiogenic factors were unable to stimulate endothelial cell proliferation. Furthermore, under nonstimulated conditions, endothelial cell proliferation was restricted to the adipose tissue and perilobular connective tissue. The endothelium within the fibrous stroma could almost never be induced to proliferate. We are now examining normal breast epithelium and stroma for the presence of angiogenic inhibitors. Angiogenic potential in this tissue appears to be the result of an interplay of angiogenic stimulators and inhibitors. Where copyrighted material is quoted, permission has been obtained to use such material.Where material from documents designated for limited distribution is quoted, permission has been obtained to use the material.Citations of commercial organizations and trade names in this report do not constitute an official Department of Army endorsement or approval of the products or services of these organizations.In conducting research using animals, the investigator(s) adhered to the "Guide for the Care and Use of Laboratory Animals," prepared by the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Resources, National Research Council (NIH Publication No. 86-23, Revised 1985).For the protection of human subjects, the investigator(s) eed to policies of applicable Federal Law 45 CFR 46.In...